Back
Salesforce Vs. Ascendis Pharma AS Industry Stock Comparison
Buy
55
CRM
Salesforce
Last Price:
$324.56
Seasonality Move:
7.65%
Sell
35
ASND
Ascendis Pharma AS
Last Price:
$128.13
Seasonality Move:
6.98%
Buy
55
Salesforce (CRM)
is a Buy
Is Salesforce a Buy, Sell or Hold?
-
The current Salesforce [CRM] share price is $324.56. The Score for CRM is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
CRM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
35
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy, Sell or Hold?
-
The current Ascendis Pharma AS [ASND] share price is $128.13. The Score for ASND is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
ASND is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CRM Stock Price Chart
What is Salesforce's stock price today?
-
The Salesforce share price today is $324.56Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRM is experiencing selling pressure, which indicates risk of future bearish movement.
ASND Stock Price Chart
What is Ascendis Pharma AS's stock price today?
-
The Ascendis Pharma AS share price today is $128.13Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASND is experiencing selling pressure, which indicates risk of future bearish movement.
CRM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -4.5 | Sell |
Relative Strength Index (14 RSI): | 44.06 | Sell |
Chaikin Money Flow: | -3371010 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (323.89 - 348.29) | Sell |
Bollinger Bands (100): | (269.52 - 339.2) | Buy |
ASND Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.63 | Sell |
Relative Strength Index (14 RSI): | 41.37 | Sell |
Chaikin Money Flow: | -281370 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (132.04 - 139.32) | Sell |
Bollinger Bands (100): | (124.47 - 141.31) | Sell |
CRM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 322.25 | Buy |
20-day SMA: | 331.34 | Sell |
50-day SMA: | 335.33 | Sell |
200-day SMA: | 283.27 | Buy |
8-day EMA: | 323.91 | Buy |
20-day EMA: | 329.61 | Sell |
50-day EMA: | 326.68 | Sell |
200-day EMA: | 291.77 | Buy |
ASND Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 132.64 | Sell |
20-day SMA: | 136.01 | Sell |
50-day SMA: | 132.35 | Sell |
200-day SMA: | 134.15 | Sell |
8-day EMA: | 132.62 | Sell |
20-day EMA: | 134.21 | Sell |
50-day EMA: | 133.61 | Sell |
200-day EMA: | 131.63 | Sell |
Salesforce Earnings Growth & CRM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.34 per share, an increase next quarter of $0.23 per share, an increase this year of $1.84 per share, and an increase next year of $1.19 per share.
Ascendis Pharma AS Earnings Growth & ASND Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.51 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.31 per share, and an increase next year of $5.63 per share.
Salesforce Technical Analysis
Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ascendis Pharma AS Technical Analysis
Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |